Dana, by a thousand colibris SL is a technology company.
Dana, by a thousand colibris SL has raised $97K across 1 funding round.
Dana, by a thousand colibris SL has raised $97K in total across 1 funding round.
Dana, by a thousand colibris SL has raised $97K in total across 1 funding round.
Dana, by a thousand colibris SL's investors include Omnis Mundi.
Dana, by a Thousand Colibris SL is a Barcelona-based healthtech startup founded in 2020 that develops a certified digital therapeutics software called the Dana app. The app uses AI to improve mental health and integral wellbeing for women during motherhood, targeting both consumers and businesses through a subscription-based model.[1][2][3][4] It addresses postpartum challenges by providing holistic digital health solutions, including mental health monitoring and support, with clinical validation ongoing via randomized controlled trials.[1][5][6] The company has raised €1.5M in total funding, including a €0.2M round in March 2024, and employs a small team of around 2 people.[2][4]
Dana emerged from A Thousand Colibris SL, founded in 2020 in Barcelona, Spain, as a response to the mental health needs of new mothers.[1][4] Key figures include Verónica Montesinos, listed in leadership roles, and other founders such as Sven Dr. Mulfinger, though detailed backgrounds are limited in available data.[2][4] The idea likely stemmed from personal or observed gaps in maternal care, evolving into a certified digital therapeutic with early traction evidenced by its listing in Catalonia's startup ecosystem and media coverage like a 2022 La Vanguardia feature on the startup's mission to care for mothers.[1][4] Pivotal moments include securing €1.5M in funding and launching clinical trials to validate the app's efficacy.[4][6]
Dana rides the wave of digital health and AI-driven therapeutics, capitalizing on rising awareness of maternal mental health—affects up to 20% of new mothers globally, amplified by post-pandemic telehealth adoption. Timing aligns with Europe's healthtech boom, particularly in Spain's Catalonia hub, where social economy and digital health incentives foster innovation.[1] Market forces like aging populations, fertility challenges, and demand for scalable, non-pharma solutions favor Dana, positioning it amid trends in personalized medicine and women's healthtech.[1][5] It influences the ecosystem by pioneering AI for perinatal care, potentially setting standards for certified apps and encouraging B2B integrations in healthcare and employer wellness programs.[1][2]
Dana's compact team and recent €0.2M funding signal steady growth in a niche with high impact potential, likely expanding via trial results and partnerships in Europe’s healthtech networks.[2][4][6] Trends like AI regulation (e.g., EU AI Act) and rising investor interest in femtech will shape its path, with reimbursement from insurers as a key unlock. Its influence may grow by influencing policy on digital therapeutics and scaling to adjacent areas like child development, solidifying its role as a maternal health pioneer—much like how early digital tools transformed chronic care.
Dana, by a thousand colibris SL has raised $97K across 1 funding round. Most recently, it raised $97K Seed in December 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2020 | $97K Seed | Omnis Mundi |